{"filings":[{"id":1915316,"accession_number":"0001437749-26-024693","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2026-07-28T20:57:17+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Acadia Healthcare Q2 revenue flat YoY; adjusted EPS $0.38 vs $0.83; updates FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Revenue $865.8M flat YoY; same-facility revenue flat, patient days +0.8%, revenue per patient day -0.8%.","Net income $10.9M ($0.12 diluted EPS) vs $30.1M ($0.33); adjusted net income $35.1M ($0.38) vs $74.8M ($0.83).","Adjusted EBITDA $149.2M vs $201.8M; includes $28.6M PLGL reserve adjustment and $26.1M Florida supplemental payment benefit.","Operating cash flow $162.1M vs $133.5M; capex $38.6M vs $167.7M; added 240 licensed beds from new construction.","Full year 2026 financial and cash flow guidance updated; specific numbers not provided in excerpt."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":501516,"accession_number":"0001193125-26-229138","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2026-05-18T21:15:03+00:00","items":["8.01"],"status":"ready","headline":"Acadia subsidiary faces $105M jury verdict in retaliatory termination suit","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["San Diego jury awarded $35M compensatory and $70M punitive damages on May 12, 2026.","Plaintiff is a former employee of Fashion Valley CTC terminated in October 2023.","Acadia and Fashion Valley deny allegations and will challenge verdict in post-trial motions and appeal.","Company is not a party to the lawsuit; Fashion Valley is an indirect wholly owned subsidiary.","Acadia warns final outcome may differ materially due to uncertainties in litigation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93386,"accession_number":"0001193125-26-209324","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2026-05-06T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Acadia Healthcare annual meeting: directors elected, incentive plan and say-on-pay approved","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Three Class III directors elected with >73M votes each: Cancelmi, Fucci, Harris.","Second amendment to Incentive Compensation Plan approved: 80.1M for, 0.78M against, 0.05M abstain.","Non-binding say-on-pay passed with 60.9M for (75.3%) but 19.9M against (24.6%).","Ernst & Young ratified as auditor for FY 2026: 83.9M for, 1.95M against, 0.05M abstain."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93385,"accession_number":"0001437749-26-013916","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2026-04-29T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Acadia Healthcare Q1 revenue up 7.6% to $828.8M; raises FY2026 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $828.8M (+7.6% YoY); same-facility revenue +7.3%.","Adjusted EPS $0.37 vs $0.40 prior year; GAAP EPS $0.05 vs $0.09.","Adjusted EBITDA $144.2M vs $134.2M prior year (+7.5%).","Added 82 newly licensed beds in Q1; full-year adjusted EBITDA and EPS guidance raised.","Revenue per patient day +5.6%; patient days +1.6%."],"consensus_eps_estimate":null,"consensus_eps_actual":0.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":828802000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93384,"accession_number":"0001193125-26-173769","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2026-04-23T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Acadia Healthcare CFO Todd Young departs; former CFO David Duckworth returns as Interim CFO; guidance reaffirmed","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Todd Young resigns as CFO effective April 30, 2026; to join private equity-backed animal health company.","David Duckworth, former Acadia CFO (2012-2023), appointed Interim CFO effective May 1, 2026.","Interim CFO Duckworth to serve at least until permanent CEO search concludes; base salary $100K/month + $125K/quarter bonus.","Q1 2026 outlook reaffirmed: revenue $820-$830M, adj. EBITDA $130-$137M, adj. EPS $0.25-$0.30.","FY2026 guidance reaffirmed: revenue $3.37-$3.45B, adj. EBITDA $575-$610M, adj. EPS $1.30-$1.55; Q1 earnings call Apr 30."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104957,"accession_number":"0001193125-26-104272","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2026-03-12T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Acadia Healthcare appoints Dan Cancelmi to board; Wade Miquelon to retire at 2026 annual meeting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Daniel Cancelmi, former Tenet Healthcare EVP & CFO, appointed to Acadia's Board effective March 12, 2026.","Wade Miquelon will retire from the Board at the 2026 annual meeting; not standing for re-election, no disagreement.","Board size increased from 10 to 11 then will reduce to 10 after Miquelon's retirement.","Appointment follows engagement with Khrom Capital; Goldman Sachs, J.P. Morgan financial advisors.","Company states it 'continues evaluating all paths to deliver enhanced shareholder value.'"],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104956,"accession_number":"0001437749-26-005431","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2026-02-25T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Acadia Healthcare Q4 net loss $13.02/sh on $996M goodwill impairment; appoints new CEO","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $821.5M (+6.1% YoY); net loss $13.02/diluted share from $996.2M goodwill impairment.","Adjusted EBITDA $99.8M (down 35% YoY) includes $52.7M PLGL reserve adjustment.","FY 2025 adjusted EPS $2.00 vs $3.30; FY 2026 guidance: rev $3.37-3.45B, adj EPS $1.30-1.55.","Debbie Osteen appointed CEO; full-year 2025 added 1,089 licensed beds."],"consensus_eps_estimate":null,"consensus_eps_actual":-12.16,"consensus_revenue_estimate":null,"consensus_revenue_actual":3312769000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104955,"accession_number":"0001193125-26-020169","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2026-01-23T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"CEO Christopher H. Hunter departs Acadia Healthcare effective Jan 20, 2026; separation agreement disclosed","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Christopher H. Hunter resigned and left Board effective Jan 20, 2026; no successor named.","Hunter will receive 1.5x base salary plus target bonus payable over 18 months, plus $1.785M retention bonus.","Unvested equity awards forfeited except prorated PSUs based on time elapsed and performance.","Separation conditions include general release of claims and continued compliance with restrictive covenants.","Company retains cooperation rights; Hunter must return company property within two days."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104954,"accession_number":"0001437749-26-001486","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2026-01-20T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Acadia Healthcare appoints former CEO Debra Osteen as CEO; Chris Hunter departs","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Debra Osteen appointed CEO and Class I director effective January 20, 2026; previously served as CEO from 2018-2022.","Chris Hunter departed as CEO and resigned from Board effective January 20, 2026; separation agreement terms to be disclosed later.","Osteen receives base salary of $1,061,000, target bonus of 125% of salary, and option to purchase 1,125,000 shares with performance-based vesting.","Company reaffirms FY 2025 guidance: revenue $3.28B-$3.30B, Adjusted EBITDA $601M-$611M, adjusted EPS $1.94-$2.04.","Board will conduct a comprehensive search for a long-term successor while evaluating all paths to enhance shareholder value."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104953,"accession_number":"0001437749-26-001137","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2026-01-13T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Acadia Healthcare reaffirms 2025 revenue $3.28-3.30B, adj. EBITDA $601-611M, adj. EPS $1.94-2.04","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reaffirmed 2025 guidance at J.P. Morgan Healthcare Conference: revenue $3.28B-$3.30B.","Adjusted EBITDA guidance $601M-$611M; adjusted EPS guidance $1.94-$2.04.","Guidance originally given Nov 5, 2025, updated Dec 2, 2025; no changes.","Presentation webcast on Jan 13, 2026; slides available on company's website."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121213,"accession_number":"0001437749-25-036657","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2025-12-02T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Acadia Healthcare lowers 2025 guidance after actuarial review shows $49M PLGL expense increase","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Adjusted EBITDA guidance reduced to $601-611M from $650-660M; adjusted EPS to $1.94-2.04 from $2.35-2.45.","2025 PLGL expense projected ~$116M, up from $54M in 2024, driven by 168% increase in claim frequency for 2025 policy year.","Net PLGL liability expected to rise to $145-165M at year-end 2025 from $78M at end of 2024.","For 2026, PLGL expense expected between $100M and $110M, reflecting assumption of sustained claim frequency."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121212,"accession_number":"0001193125-25-274380","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2025-11-10T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Acadia Healthcare settles securities class action for $179M; no admission of liability","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Settlement of $179M resolves St. Clair County ER Sys. v. Acadia Healthcare case with no admission of liability.","Company expects ~$30M from insurance; balance funded from cash on hand and existing credit lines.","Aggregate settlement expensed in Q4 2025; excluded from adjusted EBITDA, no impact on guidance.","As of Sept 30, 2025: cash $118.7M, revolver availability $786.7M, net leverage ratio 3.4x."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121211,"accession_number":"0001437749-25-033347","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"Acadia Q3 revenue $851.6M (+4.4% YoY), net income falls; cuts full-year guidance; COO resigns","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 net income $36.2M ($0.40 diluted) vs $0.74 prior year; adjusted EPS $0.72 vs $0.91.","Adjusted EBITDA $173.0M, down from $194.3M; revenue $851.6M (+4.4%) but missed expectations.","Full-year guidance lowered: revenue $3.28-3.30B (prev $3.30-3.35B); adj EBITDA $650-660M (prev $675-700M); adj EPS $2.35-2.45 (prev $2.45-2.65).","COO Dr. Nasser Khan resigned effective Nov 3; he becomes executive advisor through Dec 31, receives $515K lump sum.","Todd Young joined as CFO on Oct 27; company initiated search for new COO, duties assumed by other executives."],"consensus_eps_estimate":null,"consensus_eps_actual":0.82,"consensus_revenue_estimate":null,"consensus_revenue_actual":2491310000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121210,"accession_number":"0001193125-25-233507","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2025-10-07T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Acadia Healthcare appoints Todd Young as CFO effective Oct 27, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Todd Young, former Elanco Animal Health CFO, appointed as Acadia Healthcare CFO effective Oct 27, 2025.","Young receives $725K annual base salary, target cash bonus of 85% of base, and one-time cash award of $460K.","Interim CFO Tim Sides will resume role as Senior VP, Operations Finance after Young's start date.","Severance package includes 12 months salary, pro-rated bonus, and full vesting of time-based equity upon qualifying termination.","Young previously served as CFO at ACADIA Pharmaceuticals (2016-2018) and Elanco Animal Health since 2018."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137858,"accession_number":"0001193125-25-221545","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2025-09-29T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Acadia Healthcare 2026 capex to drop at least $300M; Q3 same-facility patient days up 1.3%","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Total 2026 capex expected to decline at least $300M from 2025 guidance of $600-$650M.","Expects to add 500-700 beds in 2026, inclusive of beds under construction in 2025.","Q3 2025 same facility patient days growth approximately 1.3% to date.","Management participating in Jefferies 2025 Healthcare Services Conference fireside chat."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137857,"accession_number":"0001437749-25-024875","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2025-08-05T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"Acadia Q2 revenue $869M (+9.2%), adjusted EPS $0.83; CFO Dixon resigns, Sides interim","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenue $869.2M (+9.2% YoY); same-facility revenue +9.5% with 7.5% higher rev/patient day.","GAAP net income $30.1M ($0.33 EPS); adjusted income $74.8M ($0.83 EPS); Adj. EBITDA $201.8M (+7.6%).","Added 101 newly licensed beds in Q2; company provides updated 2025 guidance.","CFO Heather Dixon resigns effective Aug 15, 2025; departure not due to disagreement with management.","Timothy Sides appointed Interim CFO (Aug 16); base $445k, weekly supplement $6,140, retention bonus $500k."],"consensus_eps_estimate":null,"consensus_eps_actual":0.42,"consensus_revenue_estimate":null,"consensus_revenue_actual":1639737000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155238,"accession_number":"0001193125-25-132208","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2025-05-30T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Acadia Healthcare annual meeting elects four directors, approves compensation plan amendment, ratifies EY","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Four Class II directors elected: Bernhard 77.5M for, Grieco 71.9M, Kelly 75.6M, Waud 63.6M (broker non-votes 2.2M).","Amendment to Incentive Compensation Plan approved: 76.9M for, 3.9M against, 39K abstain, 2.2M broker non-votes.","Non-binding advisory vote on named executive officer compensation approved: 74.2M for, 6.6M against.","Frequency of advisory vote set at one year (77.7M votes for 1 year); board adopts annual frequency.","Ernst & Young ratified as independent auditor for FY2025: 80.4M for, 2.6M against, 35K abstain."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155237,"accession_number":"0001437749-25-016141","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2025-05-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Acadia Healthcare Q1 revenue $770.5M, net income $8.4M, affirms FY2025 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $770.5M, up 0.3% YoY from $768.1M; same-facility revenue +2.1%, patient days +2.2%.","Net income $8.4M ($0.09 diluted EPS); adjusted income $36.9M ($0.40 adjusted EPS).","Adjusted EBITDA $134.2M, includes ~$5M hit from one facility closure in Q1.","Added 378 new licensed beds in Q1 (90 to existing, 288 from new construction).","Full-year 2025 guidance reaffirmed; no specific numeric outlook provided."],"consensus_eps_estimate":null,"consensus_eps_actual":0.09,"consensus_revenue_estimate":null,"consensus_revenue_actual":770505000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173753,"accession_number":"0001193125-25-051083","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2025-03-10T23:59:59+00:00","items":["1.01","2.03","8.01","9.01"],"status":"ready","headline":"Acadia Healthcare prices $550M 7.375% senior notes due 2033 to repay revolver","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $550M aggregate principal of 7.375% Senior Notes due March 15, 2033.","Proceeds used to prepay outstanding borrowings under existing senior secured revolving credit line.","Notes offered at par; interest payable semi-annually starting Sep 15, 2025.","Offering upsized from previously announced $500M; closed on March 10, 2025.","Notes are senior unsecured obligations, guaranteed by certain subsidiaries."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173752,"accession_number":"0001193125-25-042573","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2025-02-28T23:59:59+00:00","items":["1.01","1.02","2.03","9.01"],"status":"ready","headline":"Acadia Healthcare enters $1.65B senior secured credit facility, extends maturities to 2030","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $1B revolver and $650M term loan, both due Feb 28, 2030; replaces $600M revolver and term loan due Mar 2026.","On closing, $650M term loan fully drawn and $550M revolver drawn; used to refinance $1.156B existing debt.","Interest at SOFR + 1.375%-2.250% or base rate + 0.375%-1.250% based on leverage; commitment fee 0.20%-0.35%.","Covenants: Total Net Leverage ≤ 5.0x (up to 5.5x for acquisitions), Interest Coverage ≥ 3.0x.","Term loan amortization starts at 2.5% in year 1, rises to 10% in year 5; secured by substantially all assets excluding realty."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173751,"accession_number":"0001437749-25-005467","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2025-02-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Acadia Healthcare Q4 2024 revenue $774.2M (+4.2%); adj. EPS $0.64; announces $300M buyback","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Q4 net income $32.6M ($0.35 diluted EPS); adjusted income $59.2M ($0.64 diluted EPS).","Same-facility revenue +4.7% YoY on patient days +3.2% and revenue per patient day +1.4%.","Adjusted EBITDA $153.1M, including $14.3M professional liability reserve adjustment and $5.0M facility closure impact.","Added 577 newly licensed beds in Q4; completed ~1,300 newly constructed beds in FY2024.","Board authorized new $300M share repurchase program; FY2025 and Q1 2025 guidance provided."],"consensus_eps_estimate":null,"consensus_eps_actual":2.78,"consensus_revenue_estimate":null,"consensus_revenue_actual":3153963000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173750,"accession_number":"0001193125-25-005003","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2025-01-13T23:59:59+00:00","items":["2.02"],"status":"ready","headline":"Acadia Healthcare Q4 same-facility patient days +3.2% YoY, in-line with prior guidance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Same-facility patient days for Q4 2024 grew 3.2% year-over-year.","Growth was within the expected range communicated on October 31, 2024.","Management presented the update at the J.P. Morgan Healthcare Conference.","No revenue, EPS, or other financial results were disclosed in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190733,"accession_number":"0001437749-24-032658","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2024-10-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Acadia Q3 revenue $815.6M (+8.7%), adj. EPS $0.91; margins expand","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Revenue $815.6M, up 8.7% YoY; adjusted EBITDA $194.3M, up 10.5% YoY (excl. provider relief funds).","Net income $68.1M ($0.74 diluted); adjusted net income $84.1M ($0.91 adjusted diluted EPS).","Same-facility revenue +8.6%: patient days +4.7%, revenue per patient day +3.6%.","Same-facility adjusted EBITDA margin improved 100 bps to 29.7% from Q3 2023.","Company updated 2024 financial guidance (specific figures not provided in excerpt)."],"consensus_eps_estimate":null,"consensus_eps_actual":2.42,"consensus_revenue_estimate":null,"consensus_revenue_actual":2379725000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207212,"accession_number":"0001193125-24-227393","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2024-09-27T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Acadia Healthcare receives federal subpoenas over admissions, billing practices","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Voluntary request from US Attorney's Office (SDNY) and grand jury subpoena from Western District of Missouri.","Subsidiary Lakeland Hospital Acquisition also received a grand jury subpoena on same matter.","Investigations focus on admissions, length of stay, and billing; Acadia fully cooperating.","Company anticipates similar document requests from SEC and possibly other agencies.","Acadia states it cannot currently predict the outcome or potential impact on operations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207211,"accession_number":"0001437749-24-024148","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2024-07-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Acadia Healthcare Q2 revenue up 8.8% to $796M; adj. EPS $0.91 provides updated 2024 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $796.0M (+8.8% YoY); same-facility revenue +8.3% (patient days +2.6%, revenue/patient day +5.6%).","Net income $78.5M ($0.85 diluted EPS); adjusted income $83.6M ($0.91 diluted EPS).","Adjusted EBITDA $187.6M (+7.6% YoY).","Added 37 beds to existing facilities; opened a 100-bed de novo facility in Mesa, AZ.","Company updated its 2024 financial guidance (details in press release)."],"consensus_eps_estimate":null,"consensus_eps_actual":1.68,"consensus_revenue_estimate":null,"consensus_revenue_actual":1564091000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":224576,"accession_number":"0001193125-24-146576","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2024-05-24T23:59:59+00:00","items":["5.02","5.03","5.07","9.01"],"status":"ready","headline":"Acadia Healthcare appoints Dr. Nasser Khan as COO; board declassified","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. Nasser Khan appointed COO effective June 30, 2024; base salary $515,000, target bonus 85%.","John Hollinsworth retiring as EVP of Operations effective June 30, 2024; consulting through Dec 31, 2024 at $10k/month.","Stockholders approved amendment to declassify board of directors at May 23, 2024 annual meeting.","Annual meeting results: Class I directors elected, say-on-pay approved (84.8M for), Ernst & Young ratified as auditor."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":224575,"accession_number":"0001437749-24-014205","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2024-05-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Acadia Healthcare Q1 revenue up 9.1% to $768.1M, adjusted EBITDA up 14.9%, affirms FY2024 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $768.1M (+9.1% YoY); same-facility revenue +9.2%; net income $76.4M ($0.83 diluted EPS).","Adjusted EBITDA $173.9M (+14.9%); adjusted EBITDA margin 22.6% (+110 bps YoY); adjusted EPS $0.84.","Affirmed full-year 2024 guidance; added 27 beds, opened one de novo facility, acquired one specialty provider and three CTCs.","Opened 100-bed acute care hospital in Mesa, AZ in April 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":0.83,"consensus_revenue_estimate":null,"consensus_revenue_actual":768051000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":243871,"accession_number":"0001437749-24-005735","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2024-02-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Acadia Healthcare Q4 2023 revenue up 10% to $742.8M; adj. EPS $0.85","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $742.8M (+10.0% YoY); same-facility revenue +10.3%.","Net income $57.7M ($0.63 diluted EPS); adjusted net income $78.3M ($0.85 diluted EPS).","Adjusted EBITDA $169.6M (+11.9% YoY, excluding PRF and prior-year reserve adjustment).","Opened 1 de novo hospital, added 98 beds, opened 2 CTCs during Q4.","Provided FY 2024 and Q1 2024 guidance; announced JV with Ascension Seton in Austin, TX."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.24,"consensus_revenue_estimate":null,"consensus_revenue_actual":2928738000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":243870,"accession_number":"0001193125-24-011225","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2024-01-19T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Acadia Healthcare adds $350M in incremental term loans under existing credit facility","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Added $350M in aggregate principal amount of incremental term loans (Second Amendment Term A Loans) on Jan 18, 2024.","Proceeds for general corporate purposes, including litigation settlements and transaction costs.","Interest rate at SOFR+1.50% or base+0.50%; maturity March 17, 2026, same as existing term loans.","Obligations guaranteed by substantially all U.S. subsidiaries and secured by substantially all assets (excluding real property).","Existing credit agreement had $600M revolver and $425M term loan; amendment increases term loan to $775M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":261279,"accession_number":"0001157523-23-001637","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2023-11-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Acadia Healthcare Q3 net loss $217.7M on $394M legal charges; revenue up 12.5%","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Revenue $750.3M, +12.5% YoY; same facility revenue +13.0%.","Net loss $217.7M ($2.39 diluted EPS) from $394.2M legal settlement expense.","Adjusted income $83.9M ($0.91 diluted EPS); Adj. EBITDA $175.9M (+13.4%).","Opened two new hospitals with JV partners and two comprehensive treatment centers in Q3."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.87,"consensus_revenue_estimate":null,"consensus_revenue_actual":2185938000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":261278,"accession_number":"0001193125-23-266248","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2023-10-30T23:59:59+00:00","items":["1.01","9.01","10.2","10.3"],"status":"ready","headline":"Acadia Healthcare settles New Mexico civil litigation for $400M, no admission of liability","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["$400M aggregate settlement to resolve three New Mexico state court cases; no admission of liability.","Payment from insurance, cash ($112.2M at June 30) and $505M revolver; due 30 days after court approval.","Settlement expense recorded in Q3 2023, excluded from adjusted EBITDA; reaffirms existing guidance.","Company affirms strong financial position with net leverage ~2.0x and sufficient capital for investments.","Settlements fully release Acadia and Desert Hills from all claims related to the lawsuits."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":261277,"accession_number":"0001193125-23-264094","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2023-10-26T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Acadia Healthcare appoints former AMA President Dr. Patrice A. Harris to Board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board increased Class III directors from two to three; Dr. Harris fills vacancy effective Oct 26, 2023, term expiring 2026.","Dr. Harris is a board-certified psychiatrist, former President of the American Medical Association, and co-founder/CEO of eMed Digital Healthcare.","She will serve on the Compliance Committee and receive standard non-employee director compensation per 2023 proxy.","Appointment adds clinical mental health and substance abuse expertise to the Board."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":261276,"accession_number":"0001193125-23-254205","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2023-10-11T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Acadia Healthcare makes progress toward settling three New Mexico lawsuits","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Filed unopposed motion to stay bond posting and execution of judgment in Inman Litigation.","Substantial progress made during mediation on Oct 6-7, 2023 toward settlement of three related cases.","Cases: Inman v. Garcia, Rael v. Garcia, Endicott-Quinones v. Garcia in New Mexico State District Court.","Agreed to provide the court a status update within 14 days of proposed order."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":278534,"accession_number":"0001157523-23-001176","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2023-07-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Acadia Healthcare Q2 revenue up 12.2%; raises FY2023 guidance; acquires Turning Point Centers","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $731.3M, up 12.2% YoY; adjusted EPS $0.92 vs $0.79 GAAP.","Adjusted EBITDA $174.5M, up 10.9% YoY, excluding $8.6M CARES Act income.","Raised FY2023 guidance: revenue $2.86-2.90B, adjusted EPS $3.25-3.50, adj. EBITDA $655-685M.","Signed definitive agreement to acquire Turning Point Centers (76-bed specialty provider in Utah); expected close in 2023.","Added 98 beds to existing facilities in Q2, totaling 204 beds in H1 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":1.51,"consensus_revenue_estimate":null,"consensus_revenue_actual":1435604000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":278533,"accession_number":"0001157523-23-001076","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2023-07-11T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Acadia Healthcare hit with $485M jury verdict in New Mexico lawsuit; intends to challenge","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Jury awarded $80M compensatory and $405M punitive damages on July 7, 2023, in third of five lawsuits.","Two prior cases settled in 2021; amounts were covered by professional liability insurance.","Two other cases remain pending; final resolution may have an adverse impact on the Company.","Company calls award far beyond precedent and intends to pursue all legal options to overturn it."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":278532,"accession_number":"0001193125-23-182040","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2023-07-05T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Acadia Healthcare appoints Brian Farley as EVP & General Counsel; Chris Howard to retire","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Brian Farley appointed EVP & General Counsel, effective July 26, 2023; previously Chief Legal Officer at GoHealth.","Chris Howard retires as EVP, General Counsel & Secretary on July 26, 2023; transition advisory through Feb 24, 2024 at $10,592/month.","David Duckworth resigns as CFO effective July 10, 2023 (previously announced); transition fee of $11,575/month.","Larry Harrod resigned as EVP of Finance effective June 30, 2023; transition fee of $10,310/month."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":296726,"accession_number":"0001193125-23-159929","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2023-06-02T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Acadia Healthcare appoints Heather Dixon as CFO effective July 10; Duckworth steps down","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Heather Dixon appointed CFO, effective July 10, 2023; previously CFO at Everside Health, SVP/CAO at Walgreens Boots Alliance.","David Duckworth steps down after 12 years as CFO; will assist transition through July 31.","Larry Harrod, EVP Finance, retires June 30; Tim Sides promoted to SVP Operations Finance assuming his responsibilities.","Company reaffirms full-year 2023 guidance as provided Feb 27 and reaffirmed April 26."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":296725,"accession_number":"0001193125-23-149461","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2023-05-19T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Acadia Healthcare shareholders re-elect directors, approve incentive plan at annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Michael J. Fucci re-elected with 74.4M for, 12.3M against; Wade D. Miquelon with 65.7M for, 21.0M against.","Amended incentive compensation plan approved (85.2M for, 1.5M against); term extended to March 2033.","Non-binding advisory vote on named executive officer compensation passed (85.6M for, 1.1M against).","Ernst & Young LLP ratified as auditor for fiscal 2023 (87.9M for, 0.6M against)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":296724,"accession_number":"0001157523-23-000620","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2023-04-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Acadia Healthcare Q1 revenue up 14.2% to $704.3M; affirms FY 2023 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $704.3M (+14.2% YoY); same-facility revenue +13.3% on 6.5% more patient days and 6.4% higher revenue per day.","Net income $66.0M ($0.72 diluted EPS); adjusted income $68.7M ($0.75 diluted EPS).","Adjusted EBITDA $151.3M, +11.6% YoY; cash and revolver availability of $548.8M, net leverage 2.2x.","FY 2023 guidance affirmed: revenue $2.82-2.88B, Adj. EBITDA $635-675M, Adj. EPS $3.10-3.40.","Added 106 beds in Q1; plans to open 4 new inpatient facilities and at least 6 CTCs in 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":0.72,"consensus_revenue_estimate":null,"consensus_revenue_actual":704267000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":317120,"accession_number":"0001157523-23-000366","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2023-02-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Acadia Healthcare Q4 revenue up 13.8% to $675.3M; guides FY2023 adj. EPS $3.10-3.40","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net income $61.1M ($0.67 diluted EPS); adjusted EPS $0.74, including $0.04 from CARES Act PRF.","Same facility revenue +9.4% YoY on 5.2% revenue per patient day and 4.0% patient day growth.","FY2023 guidance: revenue $2.82-2.88B, adj. EBITDA $635-675M, adj. EPS $3.10-3.40.","Q1 2023 guidance: revenue $690-700M, adj. EBITDA $145-150M, adj. EPS $0.70-0.74.","Added 80 beds in Q4; opened joint venture facility in Ft. Wayne and acquired four CTCs in Georgia."],"consensus_eps_estimate":null,"consensus_eps_actual":2.98,"consensus_revenue_estimate":null,"consensus_revenue_actual":2610399000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":335366,"accession_number":"0001157523-22-001710","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2022-12-07T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Acadia Healthcare issues 2023 guidance at Investor Day; revenue $2.79B-$2.86B","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Affirms 2022 guidance: revenue $2.58-2.60B, adj. EBITDA $595-605M, adj. EPS $3.00-3.10.","Provides initial 2023 guidance: revenue $2.79-2.86B, adj. EBITDA $630-680M, adj. EPS $3.10-3.45.","CEO Chris Hunter highlights growth strategy and strong demand; company operates 246 facilities.","Investor Day webcast available; replay accessible for 90 days."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":335364,"accession_number":"0001157523-22-001454","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K/A","filed_at":"2022-11-01T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Acadia Q3 revenue $666.7M (+13.5% YoY); adj. EPS $0.86; narrows FY2022 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $666.7M, +13.5% YoY; same facility revenue +10.2% on 6.9% revenue per patient day and 3.1% patient day growth.","Net income $71.1M ($0.78 diluted EPS); adjusted EPS $0.86 ($0.80 excl. Provider Relief Fund income).","Adjusted EBITDA $162.8M (incl. $7.7M PRF); excl. PRF $155.1M.","FY2022 guidance narrowed: revenue $2.58-2.60B; adj. EPS $3.13-3.23 (incl. PRF) / $3.00-3.10 (excl.).","Cash $93.4M, $515M revolver available; net leverage ~2.1x; repaid Medicare advances and payroll tax deferrals."],"consensus_eps_estimate":null,"consensus_eps_actual":2.31,"consensus_revenue_estimate":null,"consensus_revenue_actual":1935104000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":335365,"accession_number":"0001157523-22-001443","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2022-10-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Acadia Healthcare Q3 2022: revenue up 13.5%, adj. EPS $0.86, narrows FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $666.7M (+13.5% YoY); same-facility revenue +10.2% on 6.9% revenue/patient day and 3.1% patient day growth.","Net income $71.1M ($0.78 diluted EPS); adjusted EPS $0.86 (incl. $0.06 from PRF); ex-PRF adj. EPS $0.80.","Adjusted EBITDA $162.8M (incl. $7.7M PRF); ex-PRF $155.1M; net leverage ratio ~2.1x; $515M revolver available.","Narrowed 2022 guidance: revenue $2.58-2.60B; Adj. EBITDA (excl. PRF) $595-605M; Adj. EPS $3.00-3.10 (excl. PRF).","Added 132 beds in Q3, opened 60-bed children's hospital in Chicago and 2 CTCs; on track for ~300 beds in 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":2.31,"consensus_revenue_estimate":null,"consensus_revenue_actual":1935104000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":352796,"accession_number":"0001157523-22-000932","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2022-07-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Acadia Healthcare Q2 revenue up 11.9% to $651.7M; raises 2022 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Adjusted diluted EPS $0.91 vs $0.84 ex-PRF; net income $80.1M.","Same-facility revenue +8.5%; revenue per patient day +7.8%, patient days +0.7%.","Raised 2022 guidance: revenue $2.56-2.60B, adj. EBITDA (incl. PRF) $591.5-621.5M.","Added 78 beds in H1; on track for ~300 beds in 2022; new CTC opened in Virginia.","New JVs announced with Tufts Medicine (144-bed hospital) and ECU Health (144-bed)."],"consensus_eps_estimate":null,"consensus_eps_actual":1.54,"consensus_revenue_estimate":null,"consensus_revenue_actual":1268372000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":370397,"accession_number":"0001193125-22-185179","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2022-06-29T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Acadia Healthcare appoints R. David Kelly as independent director","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["R. David Kelly elected as Class II director effective June 28, 2022, filling a board seat increase.","Term expires at the 2025 annual meeting; no committee assignments yet.","Kelly brings 35+ years in financial advisory and real estate; founder/managing partner of StraightLine Realty Partners.","Previous roles include Goldman Sachs, Salomon Brothers, and chairman of Texas Teacher Retirement System.","He will receive standard non-employee director compensation under the existing plan."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":370396,"accession_number":"0001193125-22-155213","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2022-05-20T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Acadia Healthcare annual meeting elects directors, approves say-on-pay and auditor","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Jason R. Bernhard elected with 83,048,381 votes; William F. Grieco with 63,327,920; Reeve B. Waud with 46,059,659.","Non-binding advisory vote on executive compensation approved: 83,326,381 for, 1,142,179 against.","Ratification of Ernst & Young as independent auditor for FY2022 approved: 85,844,983 for, 599,745 against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":370395,"accession_number":"0001157523-22-000544","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2022-05-03T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Acadia Healthcare Q1 revenue up 11.9% to $616.7M; reaffirms FY2022 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $616.7M (+11.9% YoY); same-facility revenue +8.6% on 6.2% higher revenue per patient day and 2.2% more patient days.","Adjusted EBITDA $135.5M vs $119.5M YoY; net income $60.8M ($0.67 diluted EPS); adjusted EPS also $0.67.","Affirms FY2022 guidance: revenue $2.55-2.60B, Adj. EBITDA $575-610M, adj. EPS $2.85-3.15.","New CEO Chris Hunter notes strong start; added 28 beds in Q1, plans ~300 beds in 2022, six de novo CTCs and JV openings.","Balance sheet: $140.4M cash, net leverage ~2.3x, $440M available on revolver; repaid $10M on credit facility."],"consensus_eps_estimate":null,"consensus_eps_actual":0.67,"consensus_revenue_estimate":null,"consensus_revenue_actual":616653000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":370394,"accession_number":"0001157523-22-000389","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2022-04-04T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Acadia Healthcare appoints Christopher Hunter as new CEO, effective April 11, 2022","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Christopher Hunter named CEO and director; effective April 11, 2022; previously at Humana, TriZetto, BlueCross BlueShield.","CEO compensation: $1M base salary, 100% target bonus (max 200%), $1M RSUs (4-yr vest), $3.5M PSUs (target, 2022-2024).","Debbie Osteen to provide transition advisory services for $20,000/month; remains on Acadia Board.","Board expanded from 9 to 10 directors to accommodate Hunter's appointment.","Severance: 1.5x (salary+target) for non-CIC without cause/good reason; 2x for CIC; equity vesting provisions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":389493,"accession_number":"0001157523-22-000270","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2022-02-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Acadia Healthcare Q4 revenue $593.5M, adjusted EPS $0.81; guides 2022 rev $2.55-2.60B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $593.5M, same facility +10.7%; adjusted EBITDA $156.1M.","Net income $70.3M ($0.77 diluted); adjusted EPS $0.81 ($0.67 ex-PRF).","Acquired CenterPointe Behavioral Health for $139M cash on Dec 31, 2021.","2022 guidance: rev $2.55-2.60B, adj. EBITDA $575-610M, adj. EPS $2.85-3.15.","Opened five new CTCs in Q4; plans 6-10 in 2022; announced three new JV partnerships."],"consensus_eps_estimate":null,"consensus_eps_actual":2.1,"consensus_revenue_estimate":null,"consensus_revenue_actual":2314394000.0,"consensus_period":"2021-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":389492,"accession_number":"0001193125-22-024575","cik":1520697,"company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","form_type":"8-K","filed_at":"2022-02-01T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Acadia CEO Debbie Osteen extends employment to March 31, 2022 for transition; $900K bonus","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Debbie Osteen to step down as CEO on date set by Board, but remains a director until term ends.","Side letter extends employment through March 31, 2022 for transition services.","Osteen eligible for $900,000 cash retention bonus contingent on service through March 31, 2022.","2019 and 2020 equity awards time-vesting components accelerated to January 31, 2022; performance awards remain outstanding."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":2185136546.30137,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-02-01T23:59:59+00:00|389492"}